PT 2.75$

Great find biowin GREAT FIND!

7k for a cheap unknown

PTs revised to .0899, .12, .40 +

$KASPA

I went with my heart and started Jason Day. Lol someday he’s going to sink a putt weeeeeee

ALXO under $10
https://investorshub.advfn.com/uimage/uploads/2024/7/4/xqhxzIMG_9249.gif

The Exponential Age: Liquidity Will Continue To Surge Into 2025 | Raoul Pal - VIDEO

https://www.youtube.com/watch?v=jdAwPVJpRpw

Shermann

learningcurve2020,

Your CDMO argument didn’t do much to change the vote. Are you still hoping for cheaper shares for the perps to cover with or friends to take a long position in hopes of gaining a toe hold in the company?; ). Best wishes.

Perhaps Georgejjl means that patients were allowed to stay on co-administered SOC. As I recall Missling did at one point say that most patients did indeed continue on Donepezil etc. during the P2b/3 trial.

REPL under $10
https://investorshub.advfn.com/uimage/uploads/2024/7/4/ubjgtIMG_9248.gif

These aren't the droids you're looking for. Just smaller actions/distributions being settled.

jour_trader: "$70M has no realistic basis whatsoever."

11 months later...

jour_trader: "Need to have $100M in annual rev. Will we hit that in FY25."

WTF!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!???????????????????????

KALA under $10
https://investorshub.advfn.com/uimage/uploads/2024/7/4/u[qdaIMG_9247.gif

Happy fourth! Tomorrow will be green and next week things will really start heating up!!!

I don't even respond to that oxymoron. Lol

no- rock bottom will be getting swept this weekend - don't worry though this weekend will be just what the doctor ordered.

The demand is growing yet the value of lwlg is declining.

Followed by “0” LOL

Happy 4th of July the fuse has been lit.

He just posted his uplist request on twitter. Up listing to the QB.

You must be talking about the private CDMO's??

>>And remember, freedom isn't free. It requires vigilance to guard against those who exploit it for financial gain.

I had hoped revenues would have shown up already

We have a whopping 50K in revenue. Aint that sumtin

I would love to know if A2-73 and DZP together is any different than A2-73 without DZP.

DZP of course is likely to represented in both the placebo and drug arms in similar proportions, so subgroup analysis specifically comparing patients on DZP or not would need to be done.